ArticleRadiation oncology (London, England)2023

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.

Matthias Stechele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.